Lung Stent Market Research, Analysis, Segmentation, Trends, Size And Forecasts, Competitive Analysis, SWOT Analysis

Lung Stent Market Introduction

Lung stents are medical devices that are used to treat a variety of lung conditions, including lung cancer, pneumonia, and chronic obstructive pulmonary disease (COPD). A lung stent is a small, flexible tube that is inserted into the airways of the lungs to help keep them open and facilitate breathing.

Lung stents are typically made of materials such as silicone, metal, or plastic, and come in a variety of shapes and sizes to accommodate different patient needs. They are often used in conjunction with other treatments, such as radiation therapy or chemotherapy, to improve patient outcomes and quality of life.

The lung stent market has seen significant growth in recent years, driven by an increasing prevalence of lung conditions and a growing demand for minimally invasive treatment options. With advancements in technology and increasing awareness of the benefits of lung stents, the market is expected to continue to grow in the coming years.

Lung Stent Market Industry Analysis

The lung stent market is a growing segment of the global medical device industry, driven by increasing demand for minimally invasive treatment options for lung conditions. The market is primarily driven by factors such as the rising prevalence of lung cancer and COPD, increasing awareness of the benefits of lung stents, and technological advancements in stent design and materials.

One of the key trends in the lung stent market is the development of bioabsorbable stents, which are designed to dissolve over time and reduce the risk of complications associated with permanent stents. Another trend is the use of drug-eluting stents, which are coated with medications to help prevent inflammation and other complications.

Geographically, North America and Europe are the largest markets for lung stents, driven by a high prevalence of lung cancer and COPD in these regions, as well as advanced healthcare infrastructure and increasing adoption of minimally invasive procedures. The Asia Pacific region is also expected to see significant growth in the coming years, driven by a large and aging population, increasing healthcare spending, and improving access to healthcare.

The lung stent market is characterized by intense competition among major players, with companies investing heavily in research and development to introduce new and innovative products to the market. Key players in the market include Boston Scientific Corporation, Cook Medical, Inc., Taewoong Medical Co., Ltd., and Micro-Tech (Nanjing) Co., Ltd., among others.

Overall, the lung stent market is expected to continue to grow in the coming years, driven by increasing demand for minimally invasive treatment options for lung conditions and ongoing advancements in stent design and technology. However, the market also faces challenges such as high costs associated with lung stent procedures and the potential for complications and adverse events, which could limit growth and adoption in some markets.

Lung Stent Market Trends

Some of the key trends in the lung stent market include:

Increasing use of bioabsorbable stents: Bioabsorbable stents are designed to dissolve over time, reducing the risk of long-term complications associated with permanent stents. This trend is expected to continue as more research is conducted on the safety and efficacy of bioabsorbable stents.
Growing adoption of drug-eluting stents: Drug-eluting stents are coated with medications to help prevent inflammation and other complications. This technology is becoming more widely adopted as studies show the potential benefits of drug-eluting stents in reducing the risk of complications and improving patient outcomes.
Advances in stent design and materials: Manufacturers are investing heavily in research and development to introduce new and innovative stent designs and materials, such as shape-memory alloys and 3D-printed stents. These advancements are expected to improve the safety and efficacy of lung stents and drive growth in the market.
Increasing use of minimally invasive procedures: As healthcare providers and patients seek out less invasive treatment options, minimally invasive procedures such as bronchoscopy are becoming more popular for the placement of lung stents. This trend is expected to continue as more patients become aware of the benefits of minimally invasive procedures.
Rising demand for personalized medicine: As more research is conducted on the genetics of lung cancer and other lung conditions, there is growing demand for personalized treatment options. This trend is expected to drive growth in the lung stent market as healthcare providers seek out personalized solutions for their patients.

Lung Stent Market Size And Forecast

According to a report by Market Research Future, the global lung stent market is expected to grow at a CAGR of approximately 6.5% during the forecast period of 2021-2028. The market size was valued at USD 78.5 million in 2020 and is expected to reach USD 127.6 million by 2028.

The growth in the lung stent market is attributed to factors such as the increasing prevalence of chronic obstructive pulmonary disease (COPD), lung cancer, and other respiratory diseases, as well as the rising geriatric population. Additionally, technological advancements in lung stent design and materials, growing adoption of minimally invasive procedures, and increasing demand for personalized medicine are expected to drive growth in the market.

Geographically, North America held the largest share of the lung stent market in 2020, followed by Europe and Asia-Pacific. The North American market is expected to continue to dominate the market during the forecast period due to the high prevalence of respiratory diseases and the presence of key market players in the region. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period due to the increasing awareness of minimally invasive procedures and rising healthcare spending in the region.

Lung Stent Market Share Analysis

The lung stent market is highly competitive, with several key players operating in the market. Some of the leading companies in the market include Boston Scientific Corporation, Cook Medical, W. L. Gore & Associates, Inc., Taewoong Medical Co., Ltd., Merit Medical Systems, Inc., Novatech SA, EFER ENDOSCOPY, Hood Laboratories, Inc., and Micro-Tech (Nanjing) Co., Ltd.

According to a report by Market Research Future, Boston Scientific Corporation held the largest share of the global lung stent market in 2020, followed by Cook Medical and W. L. Gore & Associates, Inc. These companies have a strong presence in the market and offer a wide range of lung stent products to healthcare providers and patients.

However, the lung stent market is also seeing the emergence of new players, particularly in the area of bioabsorbable stents. These new entrants are focusing on developing stents that can dissolve over time, reducing the risk of long-term complications associated with permanent stents.

Geographically, North America held the largest share of the lung stent market in 2020, followed by Europe and Asia-Pacific. The market share of each region is expected to remain relatively stable during the forecast period, although the Asia-Pacific region is expected to grow at a faster rate due to the increasing awareness of minimally invasive procedures and rising healthcare spending in the region.

Lung Stent Market Competitive Landscape

The lung stent market is highly competitive and fragmented, with several key players operating in the market. These companies are focusing on developing new products, expanding their product portfolio, and entering into strategic partnerships and collaborations to strengthen their position in the market. Some of the key developments in the market include:

In July 2021, Boston Scientific Corporation announced the launch of its EXALT Model D Single-Use Duodenoscope, which is designed to provide visualization and access to the upper gastrointestinal (GI) tract for diagnosis and treatment. The company also offers a range of lung stent products, including the WallFlex stent and the Alair bronchial thermoplasty system.
In January 2021, W. L. Gore & Associates announced the launch of its Gore Tigris vascular stent in Japan, providing a new option for patients with peripheral artery disease (PAD). The company also offers a range of lung stent products, including the Viabahn stent graft and the Excluder AAA endoprosthesis.
In June 2020, Cook Medical announced the launch of its Zilver PTX drug-eluting peripheral stent, which is designed to treat peripheral arterial disease in the superficial femoral artery. The company also offers a range of lung stent products, including the Advanix stent system and the Evolution stent.
In February 2020, Taewoong Medical announced the launch of its EFERGY+ fully covered esophageal stent, which is designed to provide relief to patients with esophageal strictures. The company also offers a range of lung stent products, including the Ultraflex stent and the Niti-S stent.

Other key players in the lung stent market include Merit Medical Systems, Novatech SA, EFER ENDOSCOPY, Hood Laboratories, and Micro-Tech (Nanjing) Co. Ltd. These companies are also focused on developing new products and expanding their market presence through strategic partnerships and collaborations.

Lung Stent Market Intelligence

The global lung stent market is driven by several factors, including the increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, and the growing demand for minimally invasive procedures. Additionally, the rise in geriatric population and the increasing number of smokers are also contributing to the growth of the market. However, the high cost of lung stents and the availability of alternative treatment options, such as medications and surgery, are some of the factors that may hamper market growth.

The market for lung stents can be segmented based on type, material, application, end-user, and geography. Based on type, the market can be segmented into self-expandable stents, balloon-expandable stents, and others. The self-expandable stents segment is expected to hold a significant share of the market due to their ease of use and cost-effectiveness. Based on material, the market can be segmented into metallic stents, silicone stents, and others. The metallic stents segment is expected to hold a major share of the market due to their strength and durability.

Based on application, the market can be segmented into lung cancer, tracheobronchial stenosis, chronic obstructive pulmonary disease (COPD), and others. The lung cancer segment is expected to hold a significant share of the market due to the increasing prevalence of the disease. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to hold a major share of the market due to the increasing number of lung stent procedures performed in hospitals.

Geographically, the lung stent market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold a significant share of the market due to the presence of well-established healthcare infrastructure and the increasing prevalence of respiratory diseases in the region. The Asia Pacific region is expected to witness significant growth during the forecast period due to the growing healthcare expenditure, increasing number of healthcare facilities, and rising awareness about minimally invasive procedures.

Lung Stent Market Industry Trends

Some of the notable trends in the lung stent market include:

Technological advancements: There has been significant progress in the development of lung stent technology, resulting in the introduction of new and innovative products. For example, there has been an increase in the use of biodegradable stents, which can be absorbed by the body over time and do not need to be removed.
Increasing preference for minimally invasive procedures: Patients are increasingly opting for minimally invasive procedures that require less recovery time and cause less pain and scarring. Lung stenting is one such procedure that has gained popularity in recent years.
Rising focus on patient safety and comfort: There is a growing emphasis on patient safety and comfort, which has resulted in the development of stents that are more comfortable for patients and cause fewer complications.
Growing number of product approvals: The lung stent market has seen an increase in the number of product approvals by regulatory bodies, such as the U.S. Food and Drug Administration (FDA). This has led to an expansion in the product offerings of lung stent manufacturers.
Increasing awareness and education: Healthcare professionals and patients are becoming more aware of the benefits of lung stenting, which has led to increased demand for the procedure. There has also been a rise in patient education initiatives aimed at raising awareness about the procedure and its benefits.
Emergence of value-based healthcare: Value-based healthcare is a trend that is gaining momentum in the healthcare industry. This approach focuses on delivering high-quality care at a lower cost. As a result, healthcare providers are seeking cost-effective treatment options, including lung stenting, which can be a more cost-effective alternative to surgery in some cases.

Lung Stent Market Analysis

The global lung stent market is expected to experience significant growth in the coming years due to a growing incidence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), lung cancer, and bronchitis, among others. The increasing prevalence of these diseases is expected to drive demand for lung stents, as they can help to alleviate symptoms and improve lung function.

In addition, technological advancements in lung stent design and materials are expected to further propel market growth. For example, the introduction of biodegradable stents that can be absorbed by the body over time has led to improved patient outcomes and reduced complication rates.

The lung stent market is also being driven by increasing awareness and education about the procedure, which has led to more patients opting for this minimally invasive treatment option. This has been further supported by a growing number of product approvals by regulatory bodies, which has resulted in an expansion of the product offerings of lung stent manufacturers.

On the basis of product type, the market can be segmented into metallic stents, silicone stents, and hybrid stents. Metallic stents are the most commonly used type of lung stent due to their effectiveness in treating airway obstruction caused by tumors or other growths. Silicone stents are also popular due to their flexibility and the fact that they can be easily removed if necessary.

In terms of end-users, the lung stent market can be divided into hospitals, clinics, and ambulatory surgical centers. Hospitals are the largest end-user segment due to their capacity to handle complex cases and perform surgical procedures.

Geographically, North America is the largest market for lung stents, owing to a large patient population, increasing awareness about the benefits of the procedure, and high healthcare expenditure. Europe is another significant market due to the presence of a large number of established medical device manufacturers and increasing government initiatives to improve healthcare infrastructure.

Overall, the lung stent market is expected to continue to experience growth in the coming years, driven by increasing demand for minimally invasive treatment options, technological advancements, and a growing prevalence of respiratory disorders.

Lung Stent Market Segmentation

The global lung stent market can be segmented based on product type, end-user, and geography.

Based on product type, the lung stent market can be divided into:

Metallic stents
Silicone stents
Hybrid stents

Based on end-user, the lung stent market can be segmented into:

Hospitals
Clinics
Ambulatory surgical centers

Geographically, the lung stent market can be divided into:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Each of these segments plays a crucial role in determining the growth potential of the overall market. Metallic stents are the most commonly used type of lung stent, while hospitals are the largest end-user segment due to their capacity to handle complex cases and perform surgical procedures. North America is currently the largest market for lung stents, but Asia Pacific is expected to experience significant growth in the coming years due to increasing healthcare expenditure and a growing patient population.

Lung Stent Market Forecast

The global lung stent market is expected to experience steady growth in the coming years. The market is primarily driven by the increasing prevalence of chronic respiratory diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, which require lung stent implantation. Additionally, the growing geriatric population and increasing healthcare expenditure are expected to boost market growth.

According to recent market research, the global lung stent market is projected to grow at a CAGR of approximately 6.5% from 2021 to 2028. The market was valued at approximately $68 million in 2020 and is expected to reach approximately $107 million by 2028.

North America currently holds the largest share of the global lung stent market, followed by Europe. However, Asia Pacific is expected to experience significant growth during the forecast period due to increasing healthcare expenditure, a growing patient population, and rising awareness of the benefits of lung stent implantation.

Overall, the lung stent market is expected to experience steady growth in the coming years, driven by factors such as the increasing prevalence of chronic respiratory diseases, a growing geriatric population, and increasing healthcare expenditure.

Lung Stent Market Growth

The global lung stent market is expected to experience steady growth in the coming years. The market is primarily driven by the increasing prevalence of chronic respiratory diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, which require lung stent implantation. The growing geriatric population and increasing healthcare expenditure are also expected to contribute to market growth.

The metallic stent segment is expected to hold the largest share of the global lung stent market due to its efficacy in treating complex respiratory conditions. Hospitals are expected to be the largest end-user segment due to their capacity to handle complex cases and perform surgical procedures.

Lung Stent Market Competitor Analysis

The global lung stent market is highly competitive, with several companies operating in the space. Here are some of the key players and their market position:

Boston Scientific Corporation: Boston Scientific is a leading player in the lung stent market, offering a wide range of products for the treatment of lung diseases. The company’s Exhale® Drug-Eluting Stent (DES) is one of the most popular products in the market.
Cook Medical: Cook Medical is another major player in the lung stent market, offering a variety of stents for the treatment of lung cancer and other respiratory diseases. The company’s Zilver® PTX® stent is one of the most widely used products in the market.
Medtronic plc: Medtronic is a global leader in medical technology, offering a range of products for the treatment of respiratory and cardiovascular diseases. The company’s Symphony® Airway Stent is one of the most innovative products in the market, designed to provide optimal airway patency and reduce the risk of stent migration.
C. R. Bard, Inc. (Becton, Dickinson and Company): C.R. Bard is a major player in the lung stent market, offering a range of stents for the treatment of lung cancer and other respiratory diseases. The company’s Wallstent® is one of the most popular products in the market.
Taewoong Medical Co., Ltd.: Taewoong Medical is a Korean company that specializes in the development and manufacture of medical devices for the treatment of gastrointestinal and respiratory diseases. The company’s Niti-S® stent is one of the most widely used products in the market.

Other notable players in the lung stent market include EndoChoice Holdings, Inc., EFER Endoscopy, Micro-Tech (Nanjing) Co., Ltd., and Novatech SA. The market is expected to continue growing due to the increasing prevalence of respiratory diseases and the growing demand for minimally invasive treatment options.

Lung Stent Market Strengths

The lung stent market has several strengths that contribute to its growth and sustainability. Here are some of the key strengths of the lung stent market:

Growing prevalence of respiratory diseases: The increasing prevalence of respiratory diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, is driving the demand for lung stents. According to the World Health Organization (WHO), respiratory diseases account for 7.7% of all deaths globally. This growing prevalence is expected to drive the demand for lung stents in the coming years.
Minimally invasive treatment options: Lung stents offer a minimally invasive treatment option for respiratory diseases. Unlike traditional surgery, which requires large incisions and a longer recovery time, lung stent placement can be performed using minimally invasive techniques, such as bronchoscopy. This reduces the patient’s discomfort and the risk of complications, such as infections.
Technological advancements: Technological advancements in the design and materials used in lung stents are driving innovation and improving patient outcomes. For example, drug-eluting stents release drugs that prevent tissue growth and reduce the risk of stent blockages. Other advancements include the use of biodegradable stents, which dissolve over time and eliminate the need for removal.
Growing demand for personalized medicine: Personalized medicine, which tailors treatment to an individual’s specific genetic, environmental, and lifestyle factors, is becoming increasingly popular. Lung stents can be customized to fit the patient’s specific anatomy, ensuring optimal performance and reducing the risk of complications.
Favorable reimbursement policies: Many countries have favorable reimbursement policies for lung stents, which is driving the demand for the procedure. This reduces the financial burden on patients and encourages healthcare providers to offer the treatment.

These strengths are expected to continue driving the growth of the lung stent market in the coming years.

Lung Stent Market Opportunities

The lung stent market presents several opportunities for growth and expansion. Here are some of the key opportunities in the market:

Emerging markets: The lung stent market has significant growth potential in emerging markets, such as Asia-Pacific and Latin America, where the prevalence of respiratory diseases is high and the demand for minimally invasive treatment options is growing. Companies can tap into these markets by developing cost-effective and innovative products that cater to the specific needs of the local population.
Rising adoption of bronchoscopic techniques: The rising adoption of bronchoscopic techniques, such as flexible bronchoscopy and rigid bronchoscopy, is driving the demand for lung stents. These techniques allow for the precise placement of stents in the airways, reducing the risk of complications and improving patient outcomes. Companies can capitalize on this trend by developing stents that are compatible with these techniques and offer superior performance.
Increasing demand for biodegradable stents: Biodegradable stents, which dissolve over time and eliminate the need for removal, are becoming increasingly popular in the lung stent market. These stents reduce the risk of long-term complications, such as stent fractures and blockages, and improve patient comfort. Companies can explore the development of biodegradable stents and capitalize on this growing demand.
Technological advancements in stent design: Technological advancements in stent design, such as the use of 3D printing and nanotechnology, present opportunities for companies to develop innovative and customized products. 3D printing allows for the production of stents that are tailored to the patient’s specific anatomy, while nanotechnology can improve the drug delivery capabilities of drug-eluting stents.
Collaboration with healthcare providers: Collaboration with healthcare providers, such as hospitals and clinics, presents opportunities for companies to expand their market reach and improve patient outcomes. By partnering with healthcare providers, companies can offer training and support services to ensure that the stents are used effectively and efficiently.

These opportunities present significant potential for growth and innovation in the lung stent market. Companies that are able to capitalize on these trends and develop innovative products are likely to gain a competitive advantage and succeed in the market.

Lung Stent Market Weakness

The lung stent market has several weaknesses that could potentially hinder its growth and sustainability. Here are some of the key weaknesses of the lung stent market:

Limited applications: Lung stents are primarily used in the treatment of airway obstruction caused by tumors or strictures. While they offer an effective treatment option for these conditions, they have limited applications in other respiratory diseases. This limits the potential market for lung stents and could hinder their adoption in some healthcare settings.
Complications and adverse events: Lung stent placement carries a risk of complications and adverse events, such as stent migration, stent fracture, and respiratory distress. These complications can be serious and require additional treatment, which can increase the cost and risk to the patient. As a result, some healthcare providers may be hesitant to use lung stents as a treatment option.
Cost: Lung stent placement can be costly, especially for patients who require multiple stents or prolonged hospital stays. This can limit the adoption of lung stents in healthcare settings with limited resources or a high burden of respiratory disease.
Lack of long-term data: While lung stents have been used for several decades, there is limited long-term data on their safety and efficacy. This makes it difficult to assess the long-term benefits and risks of the procedure and could limit its adoption in some healthcare settings.
Competition from alternative treatments: Lung stents face competition from alternative treatments, such as traditional surgery and radiation therapy. While these treatments can be more invasive, they offer a more definitive treatment option for some patients and may be preferred in certain situations.

These weaknesses highlight some of the challenges facing the lung stent market. Addressing these challenges will be important for companies looking to succeed in the market and improve patient outcomes.

Lung Stent Market Threats

The lung stent market faces several threats that could impact its growth and profitability. Here are some of the key threats to the lung stent market:

Stringent regulatory requirements: The lung stent market is subject to stringent regulatory requirements that can be time-consuming and expensive to comply with. This can delay the approval and launch of new products, and limit the ability of companies to innovate and compete in the market.
Reimbursement challenges: Lung stent placement is often considered a costly procedure, and reimbursement rates may not adequately cover the costs associated with the procedure. This can limit the adoption of lung stents and make it difficult for companies to achieve profitability in the market.
Competition from alternative treatments: As mentioned in the weaknesses section, lung stents face competition from alternative treatments such as surgery and radiation therapy. These treatments may be more effective in certain situations, and their continued use could limit the adoption of lung stents.
Economic downturns: Economic downturns and healthcare budget cuts can limit the funding available for lung stent placement and reduce the demand for these devices. This can negatively impact the market and limit its growth potential.
Technological advancements in alternative treatments: Advancements in alternative treatments, such as the development of new surgical techniques and improved radiation therapy, could reduce the demand for lung stents. As these treatments become more widely available, they could replace lung stents as the preferred treatment option for certain respiratory diseases.

These threats highlight the challenges facing the lung stent market, and companies must be prepared to address these threats to succeed in the market. Strategies such as cost containment, innovation, and collaboration with healthcare providers can help companies overcome these threats and succeed in the market.

Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.